UCP2 and diabetes mellitus: In humans, the UCP2‐866A allele is thus associated with reduced insulin sensitivity 42 and glucose‐stimulated insulin secretion 43, diabetes in obese subjects 42, oxidative stress in diabetic people 44 and future cardiovascular risk in diabetic and non‐diabetic people 44.